Cell-free DNA as a Promising Diagnostic Biomarker in Prostate Cancer: A Systematic Review and Meta-Analysis

Figure 3

The SEN, SPE, PLR, NLR, and DOR of cfDNA in the PCa diagnosis. (a) The cfDNA’s SEN and SPE; (b) the cfDNA’s PLR and NLR; (c) the cfDNA’s DOR and related diagnostic score.

(a)

(b)

(c)